Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1485959

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1485959

Medical Implants Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

The global medical implants market is on a robust growth trajectory, expected to increase from a valuation of USD 14.75 billion in 2022 to an impressive USD 33.5 billion by the end of 2031. This growth corresponds to a high-value compound annual growth rate (CAGR) of 9.5% over the forecast period, according to the latest industry analysis by Fairfield Market Research.

Market Insights and Trends

Rising Aging Population Leading to Increased Demand for Implants

One of the significant factors driving the demand for medical implants is the increasing geriatric population globally. Elderly individuals are more susceptible to chronic conditions such as dental disorders, endovascular diseases, orthopedic issues, and cardiovascular diseases, necessitating the use of various implants, including heart and kidney implants, eye implants, and artificial joints.

Growing Prevalence of Chronic Diseases

The prevalence of chronic diseases continues to rise, fueling the need for medical implants. Advancements in implant technology and increasing awareness about artificial implants are also contributing to market growth. The rapid technological progress in the implant sector is expected to further drive adoption and expand market opportunities.

Challenges: High Prices and Inadequate Reimbursement Policies

Despite the positive outlook, the high cost of implantation procedures remains a significant barrier to widespread adoption. Additionally, inadequate reimbursement policies and a shortage of skilled healthcare professionals are anticipated to limit market growth.

Regional Market Dominance

North America Leads the Market

North America is projected to dominate the global medical implants market, driven by several key factors. The region benefits from significant technological advancements in medical science and a well-established healthcare infrastructure that supports the adoption of cutting-edge medical solutions. Increased healthcare expenditure in North America further propels market growth, allowing for more substantial investments in medical research, development, and the implementation of advanced implant technologies.

The high prevalence of chronic diseases such as cardiovascular conditions, diabetes, and orthopedic disorders in North America also drives the demand for medical implants. With a growing aging population, the need for implants such as artificial joints, cardiac devices, and dental implants is on the rise. Additionally, the presence of major market players and continuous product innovations contribute to the region's market dominance. North America's robust growth trajectory is expected to continue through 2031, supported by ongoing advancements in medical technology and favorable healthcare policies.

Europe and Asia-Pacific: Emerging Growth Regions

Europe is anticipated to follow North America closely in terms of market growth. The region's advanced healthcare infrastructure plays a critical role in supporting the widespread adoption of medical implants. European countries are known for their high standards of healthcare, which include the availability of sophisticated medical facilities and skilled healthcare professionals. The increasing prevalence of chronic diseases in Europe, such as cardiovascular diseases and orthopedic disorders, further drives the demand for various types of implants.

The European market also benefits from substantial investments in medical research and development, leading to continuous innovations and improvements in implant technologies. Moreover, the regulatory environment in Europe, which emphasizes patient safety and efficacy of medical devices, contributes to market growth by ensuring high-quality standards for medical implants.

The East Asia and South Asia & Pacific regions are poised for noteworthy growth in the medical implants market. These regions are experiencing a significant increase in the aging population, which is a primary driver of demand for medical implants. As people age, they are more likely to require implants for conditions such as arthritis, cardiovascular diseases, and dental problems. Additionally, the rising prevalence of chronic diseases in these regions necessitates the use of advanced medical implants.

Growing awareness of the therapeutic benefits of medical implants is also contributing to market expansion in East Asia and South Asia & Pacific. Educational initiatives and improved access to information about medical implants are encouraging more patients to opt for these solutions. Furthermore, the development of healthcare infrastructure across these regions is enhancing the capacity to perform complex implant surgeries, thereby supporting market growth.

Economic development in East Asia and South Asia & Pacific is leading to increased disposable incomes, allowing more individuals to afford advanced medical treatments, including implants. Governments in these regions are also investing in healthcare improvements, which include the establishment of new hospitals and clinics equipped with the latest medical technologies. These factors collectively drive the demand for medical implants, making East Asia and South Asia & Pacific critical growth regions in the global market.

Key Market Players

The global medical implants market is characterized by a competitive landscape with numerous mergers, acquisitions, and product launches. Major players include Johnson & Johnson Limited, Abbott Laboratories, Edwards Lifesciences Corporation, Orthofix International N.V., Novartis International AG, Sorin S.p.A, Boston Scientific Corporation, Smith & Nephew plc, Tornier N.V., and Stryker Corporation.

Global Medical Implants market is Segmented as Below:

By Product Type:

  • Orthopedic Implants
  • Cardiovascular Implants
  • Stents
  • Stent-related Implants
  • Structural Cardiac Implants
  • Spinal Implants
  • Neurostimulators
  • Opthalmic Implants
  • Dental Implants
  • Facial Implants
  • Breast Implants

By Biomaterial Type:

  • Metallic Biomaterials
  • Ceramic Biomaterials
  • Polymers Biomaterials
  • Natural Biomaterials

By Region:

  • North America
  • Europe
  • Latin America
  • East Asia
  • The Middle East & Africa
  • South Asia & Pacific

Table of Contents

1. Executive Summary

  • 1.1. Global Medical Implants Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Price Analysis, 2018 - 2023

  • 3.1. Global Average Price Analysis, by Product Type, US$ Per Unit, 2018 - 2023
  • 3.2. Prominent Factor Affecting Medical Implants Prices
  • 3.3. Global Average Price Analysis, by Region, US$ Per Unit

4. Global Medical Implants Market Outlook, 2018 - 2031

  • 4.1. Global Medical Implants Market Outlook, by Product Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Orthopedic Implants
      • 4.1.1.2. Cardiovascular Implants
      • 4.1.1.3. Stents
      • 4.1.1.4. Stent-related Implants
      • 4.1.1.5. Structural Cardiac Implants
      • 4.1.1.6. Spinal Implants
      • 4.1.1.7. Neurostimulators
      • 4.1.1.8. Ophthalmic Implants
      • 4.1.1.9. Dental Implants
      • 4.1.1.10. Facial Implants
      • 4.1.1.11. Breast Implants
  • 4.2. Global Medical Implants Market Outlook, by Biomaterial Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Metallic Biomaterials
      • 4.2.1.2. Ceramic Biomaterials
      • 4.2.1.3. Polymers Biomaterials
      • 4.2.1.4. Natural Biomaterials
  • 4.3. Global Medical Implants Market Outlook, by Region, Value (US$ Bn) and Volume (Unit), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. North America
      • 4.3.1.2. Europe
      • 4.3.1.3. Asia Pacific
      • 4.3.1.4. Latin America
      • 4.3.1.5. Middle East & Africa

5. North America Medical Implants Market Outlook, 2018 - 2031

  • 5.1. Global Medical Implants Market Outlook, by Product Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Orthopedic Implants
      • 5.1.1.2. Cardiovascular Implants
      • 5.1.1.3. Stents
      • 5.1.1.4. Stent-related Implants
      • 5.1.1.5. Structural Cardiac Implants
      • 5.1.1.6. Spinal Implants
      • 5.1.1.7. Neurostimulators
      • 5.1.1.8. Ophthalmic Implants
      • 5.1.1.9. Dental Implants
      • 5.1.1.10. Facial Implants
      • 5.1.1.11. Breast Implants
  • 5.2. Global Medical Implants Market Outlook, by Biomaterial Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Metallic Biomaterials
      • 5.2.1.2. Ceramic Biomaterials
      • 5.2.1.3. Polymers Biomaterials
      • 5.2.1.4. Natural Biomaterials
    • 5.2.2. BPS Analysis/Market Attractiveness Analysis
  • 5.3. North America Medical Implants Market Outlook, by Country, Value (US$ Bn) and Volume (Unit), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. U.S. Medical Implants Market by Product Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 5.3.1.2. U.S. Medical Implants Market by Biomaterial Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 5.3.1.3. Canada Medical Implants Market by Product Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 5.3.1.4. Canada Medical Implants Market by Biomaterial Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Europe Medical Implants Market Outlook, 2018 - 2031

  • 6.1. Global Medical Implants Market Outlook, by Product Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Orthopedic Implants
      • 6.1.1.2. Cardiovascular Implants
      • 6.1.1.3. Stents
      • 6.1.1.4. Stent-related Implants
      • 6.1.1.5. Structural Cardiac Implants
      • 6.1.1.6. Spinal Implants
      • 6.1.1.7. Neurostimulators
      • 6.1.1.8. Ophthalmic Implants
      • 6.1.1.9. Dental Implants
      • 6.1.1.10. Facial Implants
      • 6.1.1.11. Breast Implants
  • 6.2. Global Medical Implants Market Outlook, by Biomaterial Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Metallic Biomaterials
      • 6.2.1.2. Ceramic Biomaterials
      • 6.2.1.3. Polymers Biomaterials
      • 6.2.1.4. Natural Biomaterials
  • 6.3. Europe Medical Implants Market Outlook, by Country, Value (US$ Bn) and Volume (Unit), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Germany Medical Implants Market by Product Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 6.3.1.2. Germany Medical Implants Market by Biomaterial Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 6.3.1.3. U.K. Medical Implants Market by Product Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 6.3.1.4. U.K. Medical Implants Market by Biomaterial Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 6.3.1.5. France Medical Implants Market by Product Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 6.3.1.6. France Medical Implants Market by Biomaterial Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 6.3.1.7. Italy Medical Implants Market by Product Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 6.3.1.8. Italy Medical Implants Market by Biomaterial Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 6.3.1.9. Turkey Medical Implants Market by Product Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 6.3.1.10. Turkey Medical Implants Market by Biomaterial Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 6.3.1.11. Russia Medical Implants Market by Product Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 6.3.1.12. Russia Medical Implants Market by Biomaterial Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 6.3.1.13. Rest of Europe Medical Implants Market by Product Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 6.3.1.14. Rest of Europe Medical Implants Market by Biomaterial Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Asia Pacific Medical Implants Market Outlook, 2018 - 2031

  • 7.1. Global Medical Implants Market Outlook, by Product Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Orthopedic Implants
      • 7.1.1.2. Cardiovascular Implants
      • 7.1.1.3. Stents
      • 7.1.1.4. Stent-related Implants
      • 7.1.1.5. Structural Cardiac Implants
      • 7.1.1.6. Spinal Implants
      • 7.1.1.7. Neurostimulators
      • 7.1.1.8. Ophthalmic Implants
      • 7.1.1.9. Dental Implants
      • 7.1.1.10. Facial Implants
      • 7.1.1.11. Breast Implants
  • 7.2. Global Medical Implants Market Outlook, by Biomaterial Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Metallic Biomaterials
      • 7.2.1.2. Ceramic Biomaterials
      • 7.2.1.3. Polymers Biomaterials
      • 7.2.1.4. Natural Biomaterials
    • 7.2.2. Market Attractiveness Analysis
  • 7.3. Asia Pacific Medical Implants Market Outlook, by Country, Value (US$ Bn) and Volume (Unit), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. China Medical Implants Market by Product Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 7.3.1.2. China Medical Implants Market by Biomaterial Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 7.3.1.3. Japan Medical Implants Market by Product Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 7.3.1.4. Japan Medical Implants Market by Biomaterial Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 7.3.1.5. South Korea Medical Implants Market by Product Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 7.3.1.6. South Korea Medical Implants Market by Biomaterial Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 7.3.1.7. India Medical Implants Market by Product Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 7.3.1.8. India Medical Implants Market by Biomaterial Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 7.3.1.9. Southeast Asia Medical Implants Market by Product Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 7.3.1.10. Southeast Asia Medical Implants Market by Biomaterial Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 7.3.1.11. Rest of Asia Pacific Medical Implants Market by Product Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 7.3.1.12. Rest of Asia Pacific Medical Implants Market by Biomaterial Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Latin America Medical Implants Market Outlook, 2018 - 2031

  • 8.1. Global Medical Implants Market Outlook, by Product Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Orthopedic Implants
      • 8.1.1.2. Cardiovascular Implants
      • 8.1.1.3. Stents
      • 8.1.1.4. Stent-related Implants
      • 8.1.1.5. Structural Cardiac Implants
      • 8.1.1.6. Spinal Implants
      • 8.1.1.7. Neurostimulators
      • 8.1.1.8. Ophthalmic Implants
      • 8.1.1.9. Dental Implants
      • 8.1.1.10. Facial Implants
      • 8.1.1.11. Breast Implants
  • 8.2. Global Medical Implants Market Outlook, by Biomaterial Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Metallic Biomaterials
      • 8.2.1.2. Ceramic Biomaterials
      • 8.2.1.3. Polymers Biomaterials
      • 8.2.1.4. Natural Biomaterials
    • 8.2.2. Market Attractiveness Analysis
  • 8.3. Latin America Medical Implants Market Outlook, by Country, Value (US$ Bn) and Volume (Unit), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Brazil Medical Implants Market by Product Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 8.3.1.2. Brazil Medical Implants Market by Biomaterial Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 8.3.1.3. Mexico Medical Implants Market by Product Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 8.3.1.4. Mexico Medical Implants Market by Biomaterial Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 8.3.1.5. Argentina Medical Implants Market by Product Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 8.3.1.6. Argentina Medical Implants Market by Biomaterial Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 8.3.1.7. Rest of Latin America Medical Implants Market by Product Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 8.3.1.8. Rest of Latin America Medical Implants Market by Biomaterial Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Middle East & Africa Medical Implants Market Outlook, 2018 - 2031

  • 9.1. Global Medical Implants Market Outlook, by Product Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
    • 9.1.1. Key Highlights
      • 9.1.1.1. Orthopedic Implants
      • 9.1.1.2. Cardiovascular Implants
      • 9.1.1.3. Stents
      • 9.1.1.4. Stent-related Implants
      • 9.1.1.5. Structural Cardiac Implants
      • 9.1.1.6. Spinal Implants
      • 9.1.1.7. Neurostimulators
      • 9.1.1.8. Ophthalmic Implants
      • 9.1.1.9. Dental Implants
      • 9.1.1.10. Facial Implants
      • 9.1.1.11. Breast Implants
  • 9.2. Global Medical Implants Market Outlook, by Biomaterial Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
    • 9.2.1. Key Highlights
      • 9.2.1.1. Metallic Biomaterials
      • 9.2.1.2. Ceramic Biomaterials
      • 9.2.1.3. Polymers Biomaterials
      • 9.2.1.4. Natural Biomaterials
    • 9.2.2. Market Attractiveness Analysis
  • 9.3. Middle East & Africa Medical Implants Market Outlook, by Country, Value (US$ Bn) and Volume (Unit), 2018 - 2031
    • 9.3.1. Key Highlights
      • 9.3.1.1. GCC Medical Implants Market by Product Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 9.3.1.2. GCC Medical Implants Market by Biomaterial Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 9.3.1.3. South Africa Medical Implants Market by Product Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 9.3.1.4. South Africa Medical Implants Market by Biomaterial Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 9.3.1.5. Egypt Medical Implants Market by Product Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 9.3.1.6. Egypt Medical Implants Market by Biomaterial Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 9.3.1.7. Nigeria Medical Implants Market by Product Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 9.3.1.8. Nigeria Medical Implants Market by Biomaterial Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 9.3.1.9. Rest of Middle East & Africa Medical Implants Market by Product Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
      • 9.3.1.10. Rest of Middle East & Africa Medical Implants Market by Biomaterial Type, Value (US$ Bn) and Volume (Unit), 2018 - 2031
    • 9.3.2. BPS Analysis/Market Attractiveness Analysis

10. Competitive Landscape

  • 10.1.By Product Type vs Biomaterial Type Heatmap 10.2.Company Market Share Analysis, 2023 10.3.Competitive Dashboard
  • 10.4.Company Profiles
    • 10.4.1. Johnson & Johnson Limited
      • 10.4.1.1. Company Overview
      • 10.4.1.2. Product Portfolio
      • 10.4.1.3. Financial Overview
      • 10.4.1.4. Business Strategies and Development
    • 10.4.2. Abbott Laboratories
      • 10.4.2.1. Company Overview
      • 10.4.2.2. Product Portfolio
      • 10.4.2.3. Financial Overview
      • 10.4.2.4. Business Strategies and Development
    • 10.4.3. Edwards Life-sciences Corporation
      • 10.4.3.1. Company Overview
      • 10.4.3.2. Product Portfolio
      • 10.4.3.3. Financial Overview
      • 10.4.3.4. Business Strategies and Development
    • 10.4.4. Orthofix International N.V.
      • 10.4.4.1. Company Overview
      • 10.4.4.2. Product Portfolio
      • 10.4.4.3. Financial Overview
      • 10.4.4.4. Business Strategies and Development
    • 10.4.5. Novartis International AG
      • 10.4.5.1. Company Overview
      • 10.4.5.2. Product Portfolio
      • 10.4.5.3. Financial Overview
      • 10.4.5.4. Business Strategies and Development
    • 10.4.6. Sorin S.p.A
      • 10.4.6.1. Company Overview
      • 10.4.6.2. Product Portfolio
      • 10.4.6.3. Financial Overview
      • 10.4.6.4. Business Strategies and Development
    • 10.4.7. Boston Scientific Corporation
      • 10.4.7.1. Company Overview
      • 10.4.7.2. Product Portfolio
      • 10.4.7.3. Financial Overview
      • 10.4.7.4. Business Strategies and Development
    • 10.4.8. Smith & Nephew plc
      • 10.4.8.1. Company Overview
      • 10.4.8.2. Product Portfolio
      • 10.4.8.3. Financial Overview
      • 10.4.8.4. Business Strategies and Development
    • 10.4.9. Tornier N.V.
      • 10.4.9.1. Company Overview
      • 10.4.9.2. Product Portfolio
      • 10.4.9.3. Financial Overview
      • 10.4.9.4. Business Strategies and Development
    • 10.4.10. Stryker Corporation
      • 10.4.10.1. Company Overview
      • 10.4.10.2. Product Portfolio
      • 10.4.10.3. Financial Overview
      • 10.4.10.4. Business Strategies and Development

11. Appendix

  • 11.1.Research Methodology
  • 11.2.Report Assumptions
  • 11.3.Acronyms and Abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!